Article Versions Notes

Lin Y-W, Su H-C, Raj EN, Liu K-K, Chang C-J, Hsu T-C, Cheng P-Y, Wang R-H, Lai Y-H, Chen C-H, et al. Targeting EGFR and Monitoring Tumorigenesis of Human Lung Cancer Cells In Vitro and In Vivo Using Nanodiamond-Conjugated Specific EGFR Antibody. Pharmaceutics. 2023; 15(1):111. https://doi.org/10.3390/pharmaceutics15010111

Lin, Yu-Wei, Hung-Cheng Su, Emmanuel Naveen Raj, Kuang-Kai Liu, Chien-Jen Chang, Tzu-Chia Hsu, Po-Yun Cheng, Rou-Hsin Wang, Yen-Her Lai, Chien-Hung Chen, and et al. 2023. "Targeting EGFR and Monitoring Tumorigenesis of Human Lung Cancer Cells In Vitro and In Vivo Using Nanodiamond-Conjugated Specific EGFR Antibody" Pharmaceutics 15, no. 1: 111. https://doi.org/10.3390/pharmaceutics15010111

Lin, Y.-W., Su, H.-C., Raj, E. N., Liu, K.-K., Chang, C.-J., Hsu, T.-C., Cheng, P.-Y., Wang, R.-H., Lai, Y.-H., Chen, C.-H., Lin, Y.-C., & Chao, J.-I. (2023). Targeting EGFR and Monitoring Tumorigenesis of Human Lung Cancer Cells In Vitro and In Vivo Using Nanodiamond-Conjugated Specific EGFR Antibody. Pharmaceutics, 15(1), 111. https://doi.org/10.3390/pharmaceutics15010111